MYC and lymphoid leukemia: Similar to the lymphoid maligancies that arose in the NHD13/Rag1KO mice, the lymphoid leukemias that arose in the reports cited above all developed in the context of engineered mutations, such as deletion of p19Arf, Trp53, or overexpression of Myc.